Marksans Pharma Ltd. — Capital/Financing Update 2021

Jul 23, 2021

==> picture [192 x 48] intentionally omitted <==

----- Start of picture text -----

••
Marksans Pharma Ltd.
----- End of picture text -----

BSE Limited Corporate Relation Department Phiroze Jeejeeboi Towers, Dalal Street, Mumbai - 400001. Scrip Code: 524404

National Stock Exchange of India Limited Listing Department Exchange Plaza, C-l, Block-G, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051. Symbol: MARKSANS

This is further to our intimation dated 14[th] July, 2021 and pursuant to the Special Resolution passed by the shareholders at the Extra-ordinary General Meeting held on 9[th] July, 2021, please be informed that the Board of Directors at its meeting held today, i.e., 23[rd] July, 2021, has created, issued and allotted convertible warrants on preferential basis as per details below:

• (c) 10,00,000 convertible warrants to Mr. Mark Saldanha (Promoter of the Company) at a price of INR 74.00 per warrant, being the price not less than the price determined in accordance with Chapter V ofSEBI (lCDR) Regulations, 2018; and

• (d) 4,93,24,324 convertible warrants to OrbiMed Asia IVMauritius FVCILimited at a price of INR 74.00 per warrant, being the price not less than the price determined in accordance with Chapter V ofSEBI (lCDR) Regulations, 2018.

The details as required under SEBI (LODR) Regulations, 2015 read with SEBI Circular No. CIRlCFD/CMD/4/20 15 dated September 9, 2015 with respect to the preferential issue are given in Annexure - A.

==> picture [130 x 63] intentionally omitted <==

----- Start of picture text -----

For Mm [ans] Pr~ALimited
-
~JVM
Harshavardhan P;-igrahi
Company Secretary
----- End of picture text -----

Marksans Pharma Ltd.

11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 • Tel.: +91 224001 2000 • E-mail: info@marksanspharma.com www.marksanspharma.com

Marksans Pharma Ltd.

Annexure-A Details regarding Preferential Allotment

Sr.
No.
1	Type of securities issued					(viz.	Equity		Convertible Warrants with right
	shares, convertibles etc.)								exercisable by the warrant holder to
									subscribeto one equity share ofRe. 1/-face
									value per warrant.
	Type of issuance			(further			public		Preferential Issue In accordance with
	offering, rights issue, depository receipts								Chapter V of SEBI (lCDR) Regulations,
	(ADR/GDR),		qualified			institutions			2018.
	placement, preferential			allotment etc.)
	Total number	of	securities			issued or the			(c) 10,00,000 convertible warrants
	total amount	for which the securities							each carrying a right exercisable
	issued (approximately)								by the warrant holder to subscribe
									to one equity share of face value of
									Re 1/- each per warrant.
									(d) 4,93,24,324 convertible warrants
									each carrying a right exercisable
									by the warrant holder to subscribe
									to one equity share of face value of
									Re 1/- each per warrant.
	Additional	details			in	case		of
	preferential issue
4	Name of investors								(c) Mr. Mark Saldanha (Promoter)
									(10,00,000 warrants)
									(d) OrbiMed Asia IV Mauritius FVCI
									Limited (4,93,24,324 warrants)
5	Number of Investors								2
6	Post allotment	of securities- outcome						of	(a) Issue price of each Warrant: Rs 74.
	the subscription:								(25% of the issue price of each Warrant
									paid upfront for allotment of the Warrants.
									The remaining 75% of the issue price of
									each Warrant shall be payable at the time
									of conversion of the said Warrants into
									equity shares of the Company.)
									(b) Conversion ratio of each Warrant: 1:1.
									( c) Each Warrant can be converted into one
									equity share of the Company at any time
									within eighteen months from the date of
									allotment of Warrants.
7	In case of convertibles			- intimation on					Will be intimated at the time of conversion
	conversion of	securities			or	on lapse of				_
	thetenureof the		ins1rumM~rksans					P l1arma Ltd. _f~"~_
	O h' I lI! IIUM 3.",~~· 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, s Iwara, cc: '. .• . Andheri rN), Mumbai - 400 053 • Tel.: +91224001 2000 • E-mail: info@marksanspharma.com ~~;"-J_ ..~.¢~.
						www.marksanspharma.com ~}~					~-